Review of long-term immunogenicity following HPV vaccination: Gaps in current knowledge

Autor: J. Hoes, H. Pasmans, T. M. Schurink-van ’t Klooster, F. R. M. van der Klis, R. Donken, J. Berkhof, H. E. de Melker

Publikováno v: Human Vaccines & Immunotherapeutics, Vol 18, Iss 1 (2022)

The licensed HPV vaccines are highly efficacious and induce high levels of neutralizing antibody levels, the assumed mediators of protection. However, a correlate of protection against HPV is lacking, and the evidence is still limited as to long-term

Externí odkaz: https://doaj.org/article/19c32f9d89a746358a74f00be06b5cca

Ten years of HPV vaccination in the Netherlands

Autor: Venetia Qendri, T. M. Schurink-Van ’t Klooster, Johannes Berkhof, Johannes A. Bogaards

Publikováno v: Qendri, V, Schurink-Van ’t Klooster, T M, Bogaards, J A & Berkhof, J 2018, ' Ten years of HPV vaccination in the Netherlands : current evidence and future challenges in HPV-related disease prevention ', Expert Review of Vaccines, vol. 17, no. 12, pp. 1093-1104 . https://doi.org/10.1080/14760584.2018.1547196

Introduction: Girls-only vaccination against human papillomavirus (HPV) type 16 and 18 was implemented in the Netherlands in 2009. Despite the evidence of the efficacy against precancerous lesions, cross-protection induced by the vaccine and a greate

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9095859dc94b85515c4318ae552e3f1
http://www.scopus.com/inward/record.url?scp=85058596386&partnerID=8YFLogxK